Navigation Links
BioTech Holdings Identifies and Files Patent on ProCell Mechanism of Action in Saving Limbs from Amputation
Date:10/9/2017

SAN DIEGO, Oct. 9, 2017 /PRNewswire/ -- BioTech Holdings announced today identification and patenting of a biological mechanism by which its ProCell stem cell therapy prevents limb loss in animal models of critical limb ischemia.  The Company, demonstrated that treatment with ProCell resulted in more than double the amount of limbs saved as compared to standard bone marrow stem cell administration.  Interestingly, neutralization of the molecule HGF resulted in reduction of therapeutic effect. 

Critical limb ischemia is a condition, primarily in diabetics, that causes 250,000 amputations per year in the USA.  At present there is no medical treatment for this condition and surgical approaches are applicable to less than half of patients.

ProCell is a personalized stem cell therapy using the an FDA approved peptide hormone to stimulate new blood vessel production in patients whose tissues lack oxygen, a condition termed "ischemia." In addition to critical limb ischemia, lack of oxygen is associated with heart failure and stroke.

"The identification of HGF-1 as a mechanism by which ProCell mediates its therapeutic effects is a major step forward in our developmental path towards FDA IND filing," said Thomas Ichim, Ph.D, President and CEO of BioTech Holdings. "We are aggressively filing intellectual property on this useful biomarker, which will assist us in optimizing doses as we enter formal clinical trials in the USA."

BioTech Holdings previously reported efficacy signals in a pilot study of critical limb ischemia patients.  The Company plans to file its Investigational New Drug application with the FDA before year end.

Contacts

Thomas E Ichim, Ph.D
President and Chief Executive Officer
BioTech Holdings
9255 Towne Centre Drive, #450
San Diego, CA 92121
179878@email4pr.com
858 353 4303
Twitter: @biotechholdings

 

View original content with multimedia:http://www.prnewswire.com/news-releases/biotech-holdings-identifies-and-files-patent-on-procell-mechanism-of-action-in-saving-limbs-from-amputation-300533444.html


'/>"/>
SOURCE BioTech Holdings
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Arzeda and TeselaGen Partner to Advance Biodesign Technologies for Industrial Biotechnology
2. FierceBiotech Reveals the Fierce 15 Winners of 2017
3. DrugDev to Promote Adoption of Innovative Technologies to Advance Clinical Study Efficiency at Prestigious Pharma and Biotech Industry Conferences in Q4
4. Pharma, Biotech Clinical Trial Leaders to Convene for 3rd Annual DrugDev Summit to Promote Collaboration, Technology Innovation, Engaged Sites, and More Informed Patients
5. PRC Clinical Partners With SDC to Expand ClinPulse Event Series to the Boston Biotech Hub
6. Demand for DrugDev Spark™ Soars Among Small Biotechs and Pharma Seeking Best-in-Class Technology for Clinical Trial Planning, Startup and Conduct
7. Biotech Pioneer BIOLIFE4D Submits Regulation A+ Filing with SEC for up to $50 Million Initial Public Offering
8. Lifecycle Biotechnologies Announces Promotion of Ashley Wilhelm to Customer Outcomes Manager
9. The Art of Science Inspires Residency Program at Biotech Company
10. Lesaffre Invests in Intralytix, a US Biotechnology Company
11. Panitch Schwarze Life Sciences Practice Leader Speaks at Biotechnology Conference in Shanghai
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2018)... ... October 17, 2018 , ... Dr. ... his associate, Dr. Michael Kang, are offering current and new patients the opportunity ... thanks to the emerging, proven treatment technology known as Piezosurgery® . As ...
(Date:10/16/2018)... ... 2018 , ... Infinity Healing Center, along with sixteen other ... that effectively treats pain, reduces the need for opioids, and lowers healthcare costs. ... photobiomodulation (PBM) has been effective for the treatment of medical conditions like Lyme, ...
(Date:10/11/2018)... ... October 10, 2018 , ... ... announces the appointment of Wendy Nelson, PhD, as its new CEO. , Dr. ... experience in the biotech industry. Most recently, Dr. Nelson was VP of ...
(Date:10/5/2018)... CITY, Calif. (PRWEB) , ... October 04, 2018 ... ... infectious disease diagnostics with genomics, along with Duke University, announced today at IDWeek™ ... non-invasive blood test that detects pathogen DNA in plasma, accurately identified causative pathogens ...
Breaking Biology Technology:
(Date:10/5/2018)... ... October 04, 2018 , ... ... of Illinois Extension and Monroe County Economic Development Corporation (EDC), has been ... of Food and Agriculture (NIFA) Non-Land Grant College of Agriculture (NLGCA) Capacity-Building ...
(Date:10/3/2018)... ... October 03, 2018 , ... Fit4D, a leading ... of healthcare visionary, Jimmy Lee, as Strategic Advisor to the company’s board. Mr. ... industry experience. As a Senior Executive at Anthem, he had P&L accountability for ...
(Date:10/2/2018)... ... 02, 2018 , ... Through this webinar, sponsored by Molecular Devices , ... learn the role of calcium kinetics in cardiac safety testing. The speakers for this ... Biography; and Tsang Wai Lam, an assay development scientist at PPSC. , They will ...
Breaking Biology News(10 mins):